Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Martina Jeanette Lee Porter, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Holcomb ZE, Porter ML, Kimball AB. A safety review of biologic therapies for the management of hidradenitis suppurativa and unmet needs. Expert Opin Drug Saf. 2021 Oct; 20(10):1147-1161. PMID: 33910441.
    Citations:    Fields:    
  2. Porter ML, Kimball AB. Quantifying Itch: Measurement on the Way to Management. Cutis. 2021 Apr; 107(4):167-168. PMID: 34096841.
    Citations:    Fields:    
  3. Danesh MJ, Porter M, Brag K, Salian P, Olbricht S. COVID-19 impacts on dermatologic surgery patients: A single institution experience. J Am Acad Dermatol. 2021 06; 84(6):1698-1699. PMID: 33640504.
    Citations:    Fields:    Translation:HumansPHPublic Health
  4. Price KN, Collier EK, Grogan T, Fernandez JM, Alhusayen R, Alavi A, Hamzavi IH, Lowes MA, Porter MJ, Hsiao JL, Shi VY. Physician perspectives on complementary and alternative medicine in hidradenitis suppurativa. Dermatol Ther. 2021 03; 34(2):e14851. PMID: 33547869.
    Citations:    Fields:    Translation:Humans
  5. Collier EK, Price KN, Grogan T, Fernandez JM, Seivright JR, Alhusayen R, Alavi A, Hamzavi IH, Lowes MA, Porter MJ, Shi VY, Hsiao JL. Provider perspectives on the management of hidradenitis suppurativa in pregnancy - A survey study. Int J Womens Dermatol. 2021 Jun; 7(3):346-348. PMID: 34222596.
    Citations:    
  6. Song H, Beckles A, Salian P, Porter ML. Sunscreen recommendations for patients with skin of color in the popular press and in the dermatology clinic. Int J Womens Dermatol. 2021 Mar; 7(2):165-170. PMID: 33937484.
    Citations:    
  7. Flood KS, Porter ML, Kimball AB. A visit guide for hidradenitis suppurativa-Managing a complex disease in a busy clinic. J Am Acad Dermatol. 2021 03; 84(3):e155-e160. PMID: 33010310.
    Citations:    Fields:    Translation:Humans
  8. Flood KS, Savage KT, Porter ML, Kimball AB. Treatment of psoriasis in pregnancy. Cutis. 2020 Aug; 106(2S):15-20. PMID: 33104095.
    Citations:    Fields:    
  9. Holcomb ZE, Santillan MR, Morss-Walton PC, Salian P, Her MJ, Giannotti NM, Kimball AB, Porter ML. Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy. J Am Acad Dermatol. 2020 Oct; 83(4):1215-1218. PMID: 32622141.
    Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
  10. Kumar S, Flood K, Golbari NM, Charrow AP, Porter ML, Kimball AB. Psoriasis: Knowledge, attitudes and perceptions among primary care providers. J Am Acad Dermatol. 2021 May; 84(5):1421-1423. PMID: 32526322.
    Citations:    Fields:    Translation:Humans
  11. Savage KT, Gonzalez Brant E, Flood KS, Salian P, Porter ML, Kimball AB. Publication trends in hidradenitis suppurativa from 2008 to 2018. J Eur Acad Dermatol Venereol. 2020 Sep; 34(9):1885-1889. PMID: 31968146.
    Citations: 1     Fields:    Translation:Humans
  12. Rosales Santillan M, Morss PC, Porter ML, Kimball AB. Biologic therapies for the treatment of hidradenitis suppurativa. Expert Opin Biol Ther. 2020 06; 20(6):621-633. PMID: 32077334.
    Citations: 1     Fields:    Translation:Humans
  13. Savage KT, Brant EG, Rosales Santillan M, Morss PC, Salian P, Flood KS, Porter ML, Kimball AB. Methotrexate shows benefit in a subset of patients with severe hidradenitis suppurativa. Int J Womens Dermatol. 2020 Jun; 6(3):159-163. PMID: 32637536.
    Citations: 1     
  14. Savage KT, Santillan MR, Flood KS, Charrow A, Porter ML, Kimball AB. Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients. JAAD Case Rep. 2020 Feb; 6(2):99-102. PMID: 31993474.
    Citations: 3     
  15. Morss PC, Porter ML, Savage KT, Rosales Santillan M, Giannotti N, Kimball AB. Investigating race and gender in age at onset of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020 Mar; 34(3):e139-e141. PMID: 31736152.
    Citations:    Fields:    Translation:Humans
  16. Gunasekera NS, Pahalyants V, Salian P, Basu P, Reynolds RV, Porter ML. Re-evaluating the relationship between appointment nonattendance and appointment lead time. J Am Acad Dermatol. 2020 03; 82(3):e97-e98. PMID: 31626879.
    Citations:    Fields:    Translation:Humans
  17. Flood KS, Porter ML, Kimball AB. Biologic Treatment for Hidradenitis Suppurativa. Am J Clin Dermatol. 2019 Oct; 20(5):625-638. PMID: 31140067.
    Citations: 3     Fields:    Translation:Humans
  18. Basu P, Beckles A, Porter ML, Olbricht S. Nonmelanoma skin cancers are more likely to be untreated in elderly patients. J Am Acad Dermatol. 2020 02; 82(2):505-507. PMID: 31525440.
    Citations: 1     Fields:    Translation:Humans
  19. Basu P, Elman SA, Abudu B, Beckles A, Salian P, Yanes DA, Porter ML, Reynolds RV. High-dose spironolactone for acne in patients with polycystic ovarian syndrome: A single-institution retrospective study. J Am Acad Dermatol. 2021 Sep; 85(3):740-741. PMID: 31400460.
    Citations:    Fields:    
  20. Savage KT, Flood KS, Porter ML, Kimball AB. TNF-a inhibitors in the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2019; 10:2040622319851640. PMID: 31191873.
    Citations: 4     
  21. Popatia S, Flood KS, Golbari NM, Patel PV, Olbricht SM, Kimball AB, Porter ML. Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review. J Am Acad Dermatol. 2019 Dec; 81(6):1308-1318. PMID: 31103568.
    Citations: 2     Fields:    Translation:Humans
  22. Flood KS, Porter ML, Kimball AB. Use of biologics in pregnancy: limitations stemming from clinical trials and registry experience. J Eur Acad Dermatol Venereol. 2019 08; 33(8):e276-e277. PMID: 30848856.
    Citations:    Fields:    Translation:Humans
  23. Savage KT, Flood KS, Popatia S, Golbari NM, Salian P, Kimball AB, Porter ML. Reply to: "Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment". J Am Acad Dermatol. 2019 07; 81(1):e19-e20. PMID: 30914340.
    Citations:    Fields:    
  24. Porter ML, Kimball AB. Predictions, Surprises, and the Future of the Dermatology Workforce. JAMA Dermatol. 2018 11 01; 154(11):1253-1255. PMID: 30193360.
    Citations:    Fields:    Translation:Humans
  25. Naftulin JS, Penzi LR, Manatis-Lornell A, Yasuda MR, Porter ML, Saavedra A, Senna MM. Longstanding alopecia and nail dystrophy are associated with more severe overall chronic graft-versus-host disease in adults. Bone Marrow Transplant. 2019 03; 54(3):469-472. PMID: 30214010.
    Citations:    Fields:    Translation:Humans
  26. Porter ML, Golbari NM, Lockwood SJ, Kimball AB. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa. Semin Cutan Med Surg. 2018 Sep; 37(3):182-189. PMID: 30215636.
    Citations: 5     Fields:    Translation:Humans
  27. Golbari NM, Porter ML, Kimball AB. Online communications among hidradenitis suppurativa patients reflect community needs. J Am Acad Dermatol. 2019 06; 80(6):1760-1762. PMID: 30165167.
    Citations: 1     Fields:    Translation:Humans
  28. Golbari NM, Lockwood SJ, Porter ML, Kimball AB. Assessment of treatment-seeking behaviour in patients with psoriasis. Br J Dermatol. 2018 10; 179(4):989-990. PMID: 29758088.
    Citations:    Fields:    Translation:Humans
  29. Golbari NM, Porter ML, Kimball AB. Discordance Between Patient Reported Motivations to Seek Treatment for Psoriasis Compared to Television Advertisements. J Drugs Dermatol. 2018 Aug 01; 17(8):886-887. PMID: 30124728.
    Citations: 1     Fields:    Translation:Humans
  30. Golbari NM, Porter ML, Kimball AB. Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2019 Jan; 80(1):114-119. PMID: 30003993.
    Citations: 7     Fields:    Translation:Humans
  31. Golbari NM, Lee Porter M, Kimball AB. Response to: Remission of hidradenitis suppurativa after bariatric surgery. JAAD Case Rep. 2018 Apr; 4(3):278-279. PMID: 29687072.
    Citations:    
  32. Golbari NM, Lockwood SJ, Porter ML, Kimball AB. Understanding patient engagement in psoriasis treatment. Br J Dermatol. 2018 04; 178(4):988-989. PMID: 29274082.
    Citations: 1     Fields:    Translation:Humans
  33. Golbari NM, Porter ML, Kimball AB. Current guidelines for psoriasis treatment: a work in progress. Cutis. 2018 Mar; 101(3S):10-12. PMID: 29718028.
    Citations: 6     Fields:    Translation:Humans
  34. Porter ML, Kimball AB. Comorbidities of hidradenitis suppurativa. Semin Cutan Med Surg. 2017 Jun; 36(2):55-57. PMID: 28538744.
    Citations: 5     Fields:    Translation:Humans
  35. Porter ML, Kimball AB. Hidradenitis suppurativa scoring systems: can we choose just one? Cutis. 2017 03; 99(3):156-157. PMID: 28398416.
    Citations: 1     Fields:    Translation:Humans
  36. Porter ML, Lockwood SJ, Kimball AB. Update on biologic safety for patients with psoriasis during pregnancy. Int J Womens Dermatol. 2017 Mar; 3(1):21-25. PMID: 28492050.
    Citations: 17     
  37. Chen JH, Fang DZ, Tim Goodnough L, Evans KH, Lee Porter M, Shieh L. Why providers transfuse blood products outside recommended guidelines in spite of integrated electronic best practice alerts. J Hosp Med. 2015 Jan; 10(1):1-7. PMID: 25044190.
    Citations: 6     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Porter's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (92)
Explore
_
Co-Authors (11)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.